Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Virologie (Montrouge, France)|September 24, 2022
[Chikungunya physiopathology: Infection data from acute to chronic phase]Laurence Dupuis-Maguiraga, Sonia Brun, Marion Noret, et al.
Plos Neglected Tropical Diseases|April 6, 2012
Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgiaLaurence Dupuis-Maguiraga, Marion Noret, Sonia Brun, et al.
Vaccines|August 28, 2021
Effect of Professional and Extra-Professional Exposure on Seroprevalence of SARS-CoV-2 Infection among Healthcare Workers of the French Alps: A Multicentric Cross-Sectional StudyVirginie Vitrat, Alexis Maillard, Alain Raybaud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2023
A Randomized Controlled Trial to Study the Transmission of SARS-CoV-2 and Other Respiratory Viruses During Indoor Clubbing Events (ANRS0066s ITOC Study)Liem Binh Luong Nguyen, Jeanne Goupil de Bouillé, Lola Menant, et al.
AIDS (London, England)|September 14, 2018
Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: experience from a hospital-based clinic in FranceMarion Noret, Stéphanie Balavoine, Claire Pintado, et al.
Frontiers in Public Health|November 28, 2022
Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocolJeanne Goupil de Bouillé, Liem Binh Luong Nguyen, Pascal Crépey, et al.
Contemporary Clinical Trials|June 11, 2023
Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy studyClaire Fougerou-Leurent, Christelle Delmas, Juliette Saillard, et al.
The Lancet. Infectious Diseases|January 20, 2024
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trialAchim J Kaasch, Luis Eduardo López-Cortés, Jesús Rodríguez-Baño, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 22, 2025
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trialClément R Massonnaud, Nathan Peiffer-Smadja, Pascal Poignard, et al.
Pageof 1